Resources

Brainomix, a global leader in AI-powered imaging for stroke and lung disease, today announced that five abstracts showcasing its proprietary biomarkers and advanced CT analysis technologies will be presented at the European Respiratory Society (ERS) Congress 2026, taking place September 5–9 in Barcelona, Spain.

Space is pushing the limits of human biology & any breakthroughs there may transform medicine on Earth.

LinkGevity featured on BBC News

LinkGevity CEO Dr. Carina Kern joined other global leaders across biotech, medicine, AI, and consumer health at Milken Institute Global Conference to discuss the next phase of longevity science and healthy aging.

Chris Molloy on mRNA cancer vaccine reaching Phase 3 milestone, Scancell MHRA authorisation, microbiome-based medicinal products, MHRA voucher scheme for SMEs, Scotland and data driver projects

NRG Therapeutics presented a poster on preclinical and mechanistic data of its lead clinical asset NRG5051.

Claire Smith, who sits on BIA’s Intellectual Property Advisory Committee (IPAC) committee, and James Johnston explain what the US BIOSECURE Act means for UK biotech companies

Opening for participation on September 2nd 2026, PIR International’s 2027 EU/UK Biotech & Life Sciences Board Remuneration & Diversity Study will provide a comprehensive, data-driven view of board remuneration, composition and diversity across the European and UK life sciences sector.

Agilent Technologies has been announced as a founding member of Harwell’s new CO:LABS development.

VectorBuilder and Lir Therapeutics formed a strategic collaboration to develop adeno-associated virus (AAV) capsids.

Chris Molloy on Mike Hoare, the RedX-Skye deal, Stablepharma’s fridge-free vaccine, MHRA quarterly numbers, ministerial responsibilities for UK life sciences and human biology-based models

Celebrating trailblazing biotech founders

The Milner Therapeutics Institute (MTI) is proud to be part of a new £20 million Medical Research Council (MRC) investment that will establish a UK Pre-clinical Translational Models Hub.

AI may be biotech’s biggest opportunity, but without the right data infrastructure, even the smartest models risk getting stuck at pilot stage

Mironid raises $46 million in Series B financing to advance clinical development of its treatment for rare kidney disease

BIA Annual General Meeting 2026: nominations open for BIA Board election

Tanya Bos, Non-Executive Director at BioSci Toolkit CIC, discusses securing her first NED role as part of the She Steers programme

Join the delegation as BIA boosts UK presence at BioShanghai in September

The advantages to building a business in the UK's biotech clusters

MORF-Bio has secured an Innovate UK Investor Partnerships Award, unlocking a new investment round led by Deeptech Seed Fund and matched by Helix Research and Enterprise.